CLINICAL_TRIALS
trial_result
· 2024-04-30
Clinical Trial Update: Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Summary
A Phase 2 study evaluating the efficacy and safety of PLN-74809 in idiopathic pulmonary fibrosis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pliant Therapeutics, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2024-04-30